While preclinical data on the peptide BPC-157 reveals profound therapeutic potential, clinicians are left navigating a landscape where robust human trials are conspicuously absent
Just look at this figure at the website of the organization MitoAction: B12 deficiency usually affects like mitochondrial disorders many organ systems, especially the various parts of the nervous system
See the clinical evidence for inositol (myo-inositol and D-chiro-inositol), alpha lipoic acid, vitamin B-12, folic acid, vitamin D and more
Researchers may compare BPC-157 with materials such as TB-500, BPC-157 + TB-500, KPV, and GHK-Cu when the study design supports that comparison
Pure Tested Peptides mirrors this approach by clearly labeling BPC-157 as a research-only material and by declining to provide dosing or medical guidance
It usually lasts weekly for 4-8 weeks